Aller au contenu
Aperlena

Developpement ulterieur de la plateforme TKPlate de l'EFSA pour la modelisation toxicocinetique et toxicodynamique

Original Further development of EFSA’s TKPlate Platform for toxicokinetic and toxicodynamic modelling

Clôturé Avis de préinformation
Suivre ce marché

Les offres sont closes. Une attribution ou un rectificatif sur cet avis : un e-mail quand le registre le voit. Se connecter

  1. Publié
  2. Date limite ouvert 37 jours
  3. Attribué en attente

Résumé

Résumé généré automatiquement

L'Autorite europeenne de securite des aliments a achete des services pour developper davantage sa plateforme TKPlate, application web en acces libre destinee a la modelisation toxicocinetique et toxicodynamique des substances chimiques. Les travaux comprenaient l'integration de nouveaux codes de modeles, notamment des QSAR, des modeles PBK, de bioaccumulation avancee et TKTD, la reingenierie de modeles prioritaires et le test des modules actualises au moyen d'etudes de cas. La valeur estimee etait de 80 000 EUR. La procedure negociee est desormais close aux offres; la date limite de remise etait le 2026-07-10.

Description

TK Plate is EFSA’s open-access web application implemented in R and ran in MCSim to allow fast and reliable high-throughput simulations toxicokinetic and toxicodynamic modelling of chemicals (https://r4eu.efsa.europa.eu/app/tktd). TKplate has been built within a workflow which includes a series of modules: input, forward dosimetry, reverse dosimetry, toxicodynamic, dynamic energy budget, mixtox and automated report (Bossier et al., 2023a, Dorne et al., 2023). Over the last few years, EFSA has invested in further developing TKPlate to update the platform and include new models developed under EFSA such as the ADME4NGRA and EU projects (i.e. PARC, ASPIS) and identified as priority by EFSA and the European Chemical Agency. In addition, the recently published EC road map for the pashing out of animal studies has also prioritised a number of in silico models including QSARs, physiologically-based kinetic (PBK), Toxicokinetic-Toxicodynamic (TK-TD) and bioaccumulation models to support its implementation for next generation chemical risk assessment across regulatory silos. This negotiated procedure aims to structure and test the codes of new models for their integration within TKPlate including QSARs, PBK, advanced bioaccumulation models and TKTD models. Objectives This negotiated procedure has 3 objectives: Objective 1: Objective 1: Further develop TKPlate modules through integration of physiological data for humans, animal species, available model codes in R and MCSim and modular design Objective 2: Further develop PBK, QIVIVE, advanced bioaccumulation models and TK TD models through re-engineering available priority models identified by EFSA Objective 3: Testing updated TKPlate modules and models using case studies of relevance to chemical risk assessment Selection criteria - technical and professional capacity Requirement 1: The tenderer overall must have extensive and demonstrable experience in the area of toxicokinetic and/or physiologically-based kinetic and /or bioaccumulation modelling Evidence requested: A list of three (3) major projects or publications related to the above mentioned areas of research carried out over the course of the past 5 years. Requirement 2: The tenderer must be able to provide a team of four (4) experts compliant with the following minimum expertise requirements: • One (1) senior team leader with: o A PhD in biomedical sciences or toxicology or toxicokinetics or biostatistics and At least 7 years of professional experience in applying toxicokinetic, physiologically-based kinetic and biologically-based modelling to chemical risk assessment using R and MCSim. • Three (3) senior experts with: o A PhD in biomedical sciences or toxicology or toxicokinetics or biostatistics and o At least 5 years of professional experience in the area of toxicokinetics, physiologically-based kinetic modelling, toxicokinetic-toxicodynamic modelling, biologically-based modelling and/or bioaccumulation modelling using languages of relevance including R and MCSim. Requested evidence: • Detailed CVs (max. 3 pages) of the 4 project team members proposed for the assignment. • One-page summary with the project team members, the covered profiles and indication of how the requirements are met. Requirement 3: Professional Capacity (English language capacity) All team members must have an excellent level of spoken and written English. For non-native speakers, this should be demonstrated by an official certificate of English proving a B2 level or at least 3 years of work or study in an English-speaking environment or by proof of (co)authorship of 7 scientific publications and/or reports in English language. Requested evidence: • Detailed CVs (max. 3 pages) of the project team members proposed for the assignment. • One-page summary with the project team members and indication of how the English requirement is met.

Source officielle

Source : EU Funding and Tenders Portal (SEDIA) - EU institutions

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de EU Funding and Tenders Portal (SEDIA) - EU institutions il y a 4 jours

Marchés similaires

Contexte de marché

Appel ouvert moyen · Recherche & développement
3 255 491 €
574 ouverts en Europe actuellement 98% en dessous de la moyenne du secteur
Historique de l'acheteur sur Aperlena
8 avis suivis · 0 attribués

Ne manquez plus aucun marché comme celui-ci

130 nouveaux avis pour Recherche & développement en Belgique au cours des 7 derniers jours. Recevez un e-mail quand de nouveaux avis paraissent. Gratuit.

Créer mon alerte

Raccourcis clavier

Parcourir une liste sans toucher la souris. Les raccourcis restent inactifs pendant la saisie dans un champ.

j
Résultat suivant
k
Résultat précédent
Entrée
Ouvrir le résultat
n
Page suivante
p
Page précédente
c
Comparer ce résultat
s
Ajouter ce résultat à la présélection
/
Aller au champ de recherche
?
Afficher ces raccourcis
Échap
Fermer